04
Mar

Bristol-Myers Squibb picked up FDA approval to use its new oncology treatment in lung cancer, significantly boosting the value of a therapy already expected to bring in billions each year.

…read more

Source: Bristol-Myers bags a record-fast approval for its cancer blockbuster Opdivo

    

0 No comments